| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/11/2008 | EP1928425A1 Pharmaceutical formulation containing an hmg-coa reductase inhibitor and method for the preparation thereof |
| 06/11/2008 | EP1928424A2 Controlled release pharmaceutical composition of venlafaxine hydrochloride, and process for preparation thereof |
| 06/11/2008 | EP1928420A1 Treatment of inflammation and vascular abnormalities of the eye |
| 06/11/2008 | EP1928417A2 Metronidazole-based dermatological foam and emulsions for the production thereof |
| 06/11/2008 | EP1928416A2 Metronidazole-based dermatological foam and emulsions for the production thereof |
| 06/11/2008 | EP1928414A2 Production of emulsions for intravenous injection of water-insoluble pharmaceutical compositions |
| 06/11/2008 | EP1928411A2 Use of octenidine dihydrochloride in semisolid preparations |
| 06/11/2008 | EP1928410A2 Antibiotic formulations, unit doses, kits, and methods |
| 06/11/2008 | EP1928409A2 Stable pharmaceutical composition comprising a pyrimidine-sulfamide |
| 06/11/2008 | EP1928407A1 Chronotherapeutic ocular delivery system comprising a combination of prostaglandin and a beta-blocker for treating primary glaucoma |
| 06/11/2008 | EP1928406A2 Pharmaceutical compositions with melting point depressant agents and method of making same |
| 06/11/2008 | EP1928405A1 Pharmaceutical compositions for the treatment of inner ear disorders |
| 06/11/2008 | EP1928349A2 Treatment of chronic renal failure and other conditions in domestic animals: compositions and methods |
| 06/11/2008 | EP1928244A2 Anti-inflammatory activity of phenethylisothiocyanate (peitc) and the barbarea verna seed preparation containing this compound |
| 06/11/2008 | EP1928236A2 Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors |
| 06/11/2008 | EP1928235A2 Composition and method for use in cartilage affecting conditions |
| 06/11/2008 | EP1871183A4 Supplemental dietary composition for increasing muscle size and strength |
| 06/11/2008 | EP1771446B1 Azaindole inhibitors of mtp and apob |
| 06/11/2008 | EP1750744B1 Medicament for the treatment of fungal infections, particularly aspergillosis |
| 06/11/2008 | EP1740186B1 Biodegradable intraocular implants containing prostamides |
| 06/11/2008 | EP1737435A4 Fluid composition used to simulate human synovial fluid |
| 06/11/2008 | EP1734965A4 New compositions and methods for maintaining eyelid hygiene |
| 06/11/2008 | EP1729778B1 Pharmaceutical preparation containing drospirenone for application to the skin |
| 06/11/2008 | EP1727809B1 Substituted morpholine and thiomorpholine derivatives |
| 06/11/2008 | EP1720540B1 Satraplatin for treating resistant or refractory tumors |
| 06/11/2008 | EP1685121B1 Antidiabetic compounds comprising benzothiophene derivatives |
| 06/11/2008 | EP1638933B1 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors |
| 06/11/2008 | EP1633754B1 Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors |
| 06/11/2008 | EP1620098B1 Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections |
| 06/11/2008 | EP1603908B1 Quinazoline derivatives as tgf-beta inhibitors |
| 06/11/2008 | EP1601656A4 Tetrahydroquinoline derivatives useful as serine protease inhibitors |
| 06/11/2008 | EP1599197B1 The use of antimuscarinic drugs |
| 06/11/2008 | EP1575378B1 Pulverulent phytosterol formulations |
| 06/11/2008 | EP1532150B1 Novel purine derivatives, production and use thereof as medicaments |
| 06/11/2008 | EP1517709B1 Transdermal drug delivery system |
| 06/11/2008 | EP1497293B1 (1,4)diazepino(6,7,1-ij)quinoline derivatives as anti psychotic and antiobesity agents |
| 06/11/2008 | EP1497266B1 Quinoline derivatives and their use as 5-ht6 ligands |
| 06/11/2008 | EP1492803B1 New analogs of nitrobenzylthioinosine |
| 06/11/2008 | EP1490066B1 Use of ranolazine for the preparation of a medicament for the treatment of arrhythmias |
| 06/11/2008 | EP1485348B1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 06/11/2008 | EP1480984B1 Condensed camptothecins as antitumor agents |
| 06/11/2008 | EP1463501B1 Cis-imidazolines as mdm2 inhibitors |
| 06/11/2008 | EP1451184B1 Dimeric compounds and their use as anti-viral agents |
| 06/11/2008 | EP1451182B1 Dimeric compounds and their use as anti-viral agents |
| 06/11/2008 | EP1444235B1 Reverse-turn mimetics and method relating thereto |
| 06/11/2008 | EP1420769B1 Lipid profile modulation with steroids and ppar alpha agonists |
| 06/11/2008 | EP1414794B1 Allylmercaptocaptopril compounds and uses thereof |
| 06/11/2008 | EP1392334B1 Therapeutic methods using herbal compositions |
| 06/11/2008 | EP1372621B1 Novel use of tyrosine kinase frk inhibitor |
| 06/11/2008 | EP1368032B1 Excitatory amino acid receptor antagonists |
| 06/11/2008 | EP1350262B1 Cpg-like nucleic acids and methods of use thereof |
| 06/11/2008 | EP1317188B2 Use of benzophenanthridine alkaloids as feed additives |
| 06/11/2008 | EP1313713B1 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods |
| 06/11/2008 | EP1282436B1 Treatment of acute coronary syndrome with glp-1 |
| 06/11/2008 | EP1255739B1 3-aminoquinazolin-2,4-dione antibacterial agents |
| 06/11/2008 | EP1246612B1 Osmotic device containing pseudoephedrine and fexofenadine |
| 06/11/2008 | EP1230235B1 Compounds with antibacterial and antiparasitic properties |
| 06/11/2008 | EP1197227B9 Method of the administration of drugs having binding affinity with plasma protein and preparation to be used in the method |
| 06/11/2008 | EP1165113B1 USE OF ErbB RECEPTOR LIGANDS IN TREATING DIABETES |
| 06/11/2008 | EP1086137B1 Composition and method for modulating dendritic cell-t cell interaction |
| 06/11/2008 | EP0948522B1 Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines |
| 06/11/2008 | CN101198869A Agent for preventing and treating pancreatitis |
| 06/11/2008 | CN101198618A Steroids having a mixed androgenic and progestagenic profile |
| 06/11/2008 | CN101198614A Thienopyrimidine derivative |
| 06/11/2008 | CN101198613A Substituted tetrahydroquinoline |
| 06/11/2008 | CN101198610A Process for preparing salts of 4-[[5-[(cyclopropylamino)carbonyl]-2-methylphenyl]amino]-5-methyl-n-propylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide and novel stable forms produced therein |
| 06/11/2008 | CN101198609A Aspartyl protease inhibitors |
| 06/11/2008 | CN101198608A Prodrugs of A2b adenosine receptor antagonists |
| 06/11/2008 | CN101198607A Phenylacetamides suitable as protein kinase inhibitors |
| 06/11/2008 | CN101198606A Alpha-(aryl-or heteroaryl-methyl)-beta piperidino propanamide compounds as ORL1-receptor antagonists |
| 06/11/2008 | CN101198605A N-(pyridin-2-yl)-sulfonamide derivatives |
| 06/11/2008 | CN101198604A NPY antagonists, preparation and use |
| 06/11/2008 | CN101198603A 4-(pyrid-2-yl) amino substituted pyrimidine as protein kinase inhibitors |
| 06/11/2008 | CN101198602A Saminopyrimidine derivates with tIE2 inhibiting activity |
| 06/11/2008 | CN101198598A Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 06/11/2008 | CN101198597A Preparation and use of compounds as aspartyl protease inhibitors |
| 06/11/2008 | CN101198596A 2-amino-quinaz0lin-5-ones as HSP90 inhibitors useful in treating proliferation diseases |
| 06/11/2008 | CN101198594A Process for the production of intermadiates for the preparation of tricyclic benzimidazoles |
| 06/11/2008 | CN101198590A Novel pyridine derivative and pyrimidine derivative (3) |
| 06/11/2008 | CN101198586A Biphenyl and naphthyl-phenyl hydroxamic acid derivatives |
| 06/11/2008 | CN101198583A Compounds which inhibit beta-secretase activity and methods of use |
| 06/11/2008 | CN101198582A Polymorphic crystal of 4'-{2-[ (1s, 2r) - 2- hydroxy -2- (4-hydroxyphenyl) -1- methylethylamino] ethoxy} - 3 - isopropyl-3', 5' -dimethylbiphenyl - 4 - carboxylic acid hydrochloride |
| 06/11/2008 | CN101198377A Depigmenting or brightening cosmetic composition comprising at least one oxazolin as an active ingredient |
| 06/11/2008 | CN101198375A Mixtures comprising anthranilic acid amides and cooling agents as cosmetic and pharmaceutical compositions for alleviating itching |
| 06/11/2008 | CN101198355A Agent for prevention or treatment of glaucoma |
| 06/11/2008 | CN101198354A Preventive or remedy for glaucoma |
| 06/11/2008 | CN101198342A Composition for inducing sleep comprising essential oils as active ingredients, a percutaneous pharmaceutical agent comprising thereof, and a process for producing thereof |
| 06/11/2008 | CN101198341A Antipyrotic |
| 06/11/2008 | CN101198338A Anti-hypercholesterolemic compounds |
| 06/11/2008 | CN101198337A Improvement of barrier integrarity in HIV patients by use of fatty acids |
| 06/11/2008 | CN101198336A 20-alkyl, gemini vitamin D3 compounds and methods of use thereof |
| 06/11/2008 | CN101198335A Female contraception method and medicinal box for the purpose |
| 06/11/2008 | CN101198334A Combined use of prostaglandin compound and proton pump inhibitor for the treatment of gastrointestinal disorders |
| 06/11/2008 | CN101198333A Preparation and use of aryl alkyl acid derivatives for the treatment of obesity |
| 06/11/2008 | CN101198332A Pharmaceutical composition comprising progestogens and/or estrogens and 5-methyl- (6S)-tetrahydrofolate |
| 06/11/2008 | CN101198331A Solubilization preparation |
| 06/11/2008 | CN101198330A Compositions of novel opioid compounds and method of use thereof |
| 06/11/2008 | CN101198329A Dosage regimen for prasugrel |
| 06/11/2008 | CN101198328A Solid pharmaceutical preparation containing (R)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chroman |
| 06/11/2008 | CN101198327A Solid compositions for treating middle-of-the-night insomnia |